BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6401839)

  • 21. Idiopathic thrombocytopenic purpura: examination of cellular immunity with homologous platelet antigen in vitro.
    Balázs M; Burger T; Pár A; Palka I; Deák G
    Acta Med Acad Sci Hung; 1973; 30(1):33-8. PubMed ID: 4798877
    [No Abstract]   [Full Text] [Related]  

  • 22. Controversies regarding the prophylactic management of adults with severe haemophilia A.
    Valentino LA
    Haemophilia; 2009 Dec; 15 Suppl 2():5-18, quiz 19-22. PubMed ID: 20041959
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acquired immunodeficiency in a patient with hemophilia].
    Alkan M; Kuperman O; Goldstein G; Berginer V
    Harefuah; 1986 Aug; 111(3-4):74-6. PubMed ID: 3098652
    [No Abstract]   [Full Text] [Related]  

  • 24. Impaired cell-mediated immunity in hemophilia: suppression of natural killer activity by factor VIII.
    Ablin RJ; Bartkus JM
    J Lab Clin Med; 1986 Apr; 107(4):396-7. PubMed ID: 3083030
    [No Abstract]   [Full Text] [Related]  

  • 25. Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.
    Kreuz W; Becker S; Lenz E; Martinez-Saguer I; Escuriola-Ettingshausen C; Funk M; Ehrenforth S; Auerswald G; Kornhuber B
    Semin Thromb Hemost; 1995; 21(4):382-9. PubMed ID: 8747701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary pulmonary hypertension in patients with classic hemophilia.
    Goldsmith GH; Baily RG; Brettler DB; Davidson WR; Ballard JO; Driscol TE; Greenberg JM; Kasper CK; Levine PH; Ratnoff OD
    Ann Intern Med; 1988 Jun; 108(6):797-9. PubMed ID: 3130767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

  • 28. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 30. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group.
    Schwartz RS; Abildgaard CF; Aledort LM; Arkin S; Bloom AL; Brackmann HH; Brettler DB; Fukui H; Hilgartner MW; Inwood MJ
    N Engl J Med; 1990 Dec; 323(26):1800-5. PubMed ID: 2123300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis of idiopathic thrombocytopenic purpura in children].
    Ozhegov AM
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):56-9. PubMed ID: 7024983
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemolysis caused by factor VIII concentrates.
    Orringer EP; Koury MJ; Blatt PM; Roberts HR
    Arch Intern Med; 1976 Sep; 136(9):1018-20. PubMed ID: 962445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding disorders in children: diagnosis and management.
    Lascari AD
    J Iowa Med Soc; 1968 Aug; 58(8):831-7. PubMed ID: 5690882
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
    Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
    Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic thrombocytopenic purpura in childhood.
    Singher LJ
    Minn Med; 1979 Jun; 62(6):455-8. PubMed ID: 573848
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic idiopathic thrombocytopenic purpura (ITP) in Kenyan Africans.
    Mukiibi JM; Kyobe J
    J Trop Med Hyg; 1982 Aug; 85(4):165-8. PubMed ID: 6890580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic thrombocytopenic purpura in adults.
    Horta EO; Maldonado N; Vélez-Garcia E
    Bol Asoc Med P R; 1970 Mar; 62(3):91-100. PubMed ID: 5270993
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic idiopathic thrombocytopenic purpura.
    McMillan R
    N Engl J Med; 1981 May; 304(19):1135-47. PubMed ID: 7012619
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemophilia and ITP.
    Gibson J; Joshua DE; Rickard KA
    Med J Aust; 1984 Jul; 141(1):71. PubMed ID: 6429494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.